摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)-1-cyclopenten-1-yl]-4(3H)-quinazolinone

中文名称
——
中文别名
——
英文名称
2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)-1-cyclopenten-1-yl]-4(3H)-quinazolinone
英文别名
2-(3-(4-phenyl-5,6-dihydropyridin-1(2H)-yl)cyclopent-1-enyl)quinazolin-4(3H)-one;2-[3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)cyclopenten-1-yl]-3H-quinazolin-4-one
2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)-1-cyclopenten-1-yl]-4(3H)-quinazolinone化学式
CAS
——
化学式
C24H23N3O
mdl
——
分子量
369.466
InChiKey
HYCGKBODUXUFQK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    44.7
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    参考文献:
    名称:
    Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase
    摘要:
    A successful design of conformationally restricted novel quinazolinone derivatives linked via a cyclopentene moiety as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors has been developed. One selected member of the new series, 8-chloro-2-[(3 S)-3-(4-phenylpiperidin-1-yl)cyclopent-1-en-1-yl] quinazolin-4(3H)-one (S-16d), was found to be highly potent with IC50 = 8.7 nM and good brain penetration. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.07.091
点击查看最新优质反应信息

文献信息

  • Quinazolinone derivative
    申请人:Ishida Junya
    公开号:US20050043333A1
    公开(公告)日:2005-02-24
    A quinazolinone derivatives having poly (adenosine 5′-diphospho-ribose) polymerase (PARP) inhibitory activity represented by the formula (I): wherein R 1 is substituted cyclic amino groups or optionally substituted amino group, R 2 is substituent, n means an integer of 0 to 4, and L 1 is (1) cyclo (lower) alkylene, (2) cyclo (lower) alkenylene, (3) diradical of saturated- or unsaturated monocyclic group with one or more nitrogen atom(s), which is obtained after removal of one hydrogen atom from said monocyclic group, or (4) —N(R 3 )—L 2 — (wherein R 3 is hydrogen or lower alkyl, and L 2 is lower alkylene or lower alkenylene), or its prodrug, or a salt thereof.
    具有聚腺苷酸二磷酸核糖酶(PARP)抑制活性的喹唑啉酮衍生物,其化学式表示为(I):其中R1是取代的环基或可选取代的基基团,R2是取代基,n是0到4的整数,L1是(1)环(低)烷基,(2)环(低)烯基,(3)饱和或不饱和单环基的二自由基,其中该单环基上的一个或多个氢原子被去除后获得,或(4)—N(R3)—L2—(其中R3是氢或低烷基,L2是低烷基或低烯基烷基),或其前药,或其盐。
查看更多